CCL28 and pancreatic neoplasm: By blocking CCL28 expression upon FOSL2 overexpression, we successfully suppressed Treg cell infiltration and tumour growth, providing insights into the role of FOSL2 in shaping the immune microenvironment of pancreatic cancer.